A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach

Francesco Franceschi, Davide Marsiliani, Annarita Carroccia, Nicolo' Gentiloni Silveri, E Buccelletti, C Spadaccio, M Chello, P Iacomini, G Calabrò

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

ST segment elevation myocardial infarction (STEMI) is an important risk factor of death worldwide. Significant clinical research has been done to assess ideal reperfusion strategies in the setting of STEMI, including the role of the antithrombin agents: unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Given the evidence that LMWH may be safer than UFH in the treatment of other thrombotic disorders, its role in the management of STEMI needs to be more defined.
Lingua originaleEnglish
pagine (da-a)701-710
Numero di pagine10
RivistaEuropean Review for Medical and Pharmacological Sciences
Volume15
Stato di pubblicazionePubblicato - 2011

Keywords

  • Anticoagulants
  • Bayes Theorem
  • Hemorrhage
  • Heparin, Low-Molecular-Weight
  • Humans
  • Models, Statistical
  • Myocardial Infarction
  • Randomized Controlled Trials as Topic

Fingerprint Entra nei temi di ricerca di 'A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach'. Insieme formano una fingerprint unica.

Cita questo